These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2171 related articles for article (PubMed ID: 19892051)
21. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Richardt G; Am J Cardiol; 2008 Feb; 101(4):477-82. PubMed ID: 18312761 [TBL] [Abstract][Full Text] [Related]
22. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Jeong YH; Hong MK; Lee CW; Park DW; Kim YH; Kim JJ; Park SW; Park SJ Int J Cardiol; 2008 Mar; 125(1):36-40. PubMed ID: 17521753 [TBL] [Abstract][Full Text] [Related]
23. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]
24. Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Ferenc M; Silber S; Sabin G; Tebbe U; Akin I; Hochadel M; Senges J; Kuck KH; Richardt G; J Interv Cardiol; 2012 Aug; 25(4):344-52. PubMed ID: 22409587 [TBL] [Abstract][Full Text] [Related]
25. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction. Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634 [TBL] [Abstract][Full Text] [Related]
26. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989 [TBL] [Abstract][Full Text] [Related]
27. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Kumbhani DJ; Bavry AA; Kamdar AR; Helton TJ; Bhatt DL Am Heart J; 2008 Apr; 155(4):640-7. PubMed ID: 18371470 [TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. Liistro F; Fineschi M; Grotti S; Angioli P; Carrera A; Ducci K; Gori T; Falsini G; Pierli C; Bolognese L J Am Coll Cardiol; 2010 Feb; 55(7):613-6. PubMed ID: 20170784 [TBL] [Abstract][Full Text] [Related]
35. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
36. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry. Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK; J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679 [TBL] [Abstract][Full Text] [Related]
37. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508 [TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204 [TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. De Felice F; Fiorilli R; Parma A; Menichelli M; Nazzaro MS; Pucci E; Dibra A; Musto C; Violini R Int J Cardiol; 2009 Mar; 132(3):337-41. PubMed ID: 18234373 [TBL] [Abstract][Full Text] [Related]
40. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]